Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

RIBI MELANOMA VACCINE ENTERS PHASE III

Oct. 9, 1991

NEW STOCK SYMBOL FOR APPLIED MICRO

Oct. 9, 1991

HIGH COURT REJECTS GI'S EPO PATENT APPEAL

Oct. 8, 1991

GLYCOMED TO FILE 2 MILLION-SHARE OFFERING

Oct. 8, 1991

ECOGEN SIGNS DISTRIBUTION DEAL

Oct. 8, 1991

REPLIGEN GETS PATENT RIGHTS FOR ANTIBODIES

Oct. 8, 1991

ONCOGENE COMPLETES ACQUISITION

Oct. 8, 1991

Biogen R&D Agreement for Hirulog

Oct. 8, 1991

APPOINTMENTS AND ADVANCEMENTS

Oct. 7, 1991

MID-ATLANTIC VENTURE FAIR

Oct. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...